Cryoglobulinemia secondary prevention

Cryoglobulinemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cryoglobulinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cryoglobulinemia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cryoglobulinemia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cryoglobulinemia secondary prevention
CDC on Cryoglobulinemia secondary prevention
Cryoglobulinemia secondary prevention in the news
Blogs on Cryoglobulinemia secondary prevention
Directions to Hospitals Treating Cryoglobulinemia
Risk calculators and risk factors for Cryoglobulinemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

Secondary prevention of cryoglobulinemia may include avoiding exposure to cold stimuli. Schistosoma mansoni coinfection may have a protective effect against mixed cryoglobulinaemia in hepatitis C patients.

Secondary Prevention

Secondary prevention of cryoglobulinemia include the following measures:

• Avoiding exposure to cold stimuli.
• Schistosoma mansoni coinfection may have a protective effect against mixed cryoglobulinaemia in hepatitis C patients.

References

Template:WikiDoc Sources